Friday, January 19, 2018 10:15 PM ET
Bellicum Pharmaceuticals (BLCM) sees Significant Insider Selling Continuing
One insider — Baker Bros Advisors Lp, 10% Owner — today, disposed of 880,735 shares of Bellicum Pharmaceuticals having a market value of approximately $7,219,895, as disclosed in a form 4 document filed with the SEC. There have been 2 insiders with buy/sell transactions in the past 90 days prior to this filing. These trades have resulted in the purchase of 6,206 company shares and the disposition of 23,810 company shares over this time period. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 898,339 shares and have averaged 303,584 shares per transaction over this time period.
In relation to the peer group over the last 90 days, insider buy/sell trading at Bellicum Pharmaceuticals is greater than the 280-company peer group average. Bio Therapeutic Drugs peer group saw 339 buy/sell trades during this period for an average of 1.2 transactions per company. The number of shares per buy/sell trade for Bellicum Pharmaceuticals insiders was also higher. Within the peer group there were 44,054,825 shares purchased and 41,231,595 shares sold with company insiders purchasing 12,833 shares on average.
In determining significant insider buying and selling, trades reported to the SEC that involve awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers have been eliminated in data sourced to create and write this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2018 UpTick Data Technologies. All rights reserved.